HBK Investments’s Epizyme, Inc EPZM Stock Holding History

HBK Investments’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,737	Closed	-$443K	–	1196
2019 Q1	$443K	Buy	35,737 +17,561	+97%	+$196K	0.01%	852
2018 Q4	$112K	Buy	+18,176	New	+$139K	﹤0.01%	1154
2018 Q3	–	Sell	-64,760	Closed	-$877K	–	1429
2018 Q2	$877K	Buy	+64,760	New	+$1.01M	0.01%	667
2017 Q4	–	Sell	-11,600	Closed	-$221K	–	1209
2017 Q3	$221K	Sell	11,600 -55,454	-83%	-$846K	﹤0.01%	947
2017 Q2	$1.01M	Buy	+67,054	New	+$1.01M	0.01%	564
2016 Q2	–	Sell	-12,300	Closed	-$149K	–	1138
2016 Q1	$149K	Buy	+12,300	New	+$124K	﹤0.01%	911

Other funds holding EPZM

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return